Targeting Oxphos Pathway Against Ibrutinib Resistance to Mantle Cell Lymphoma

被引：2
|
作者：
Liu, Yang
Bell, Taylor
Zhang, Hui
Sun, Yuting
Li, Carrie J.
Feng, Ningping
Huang, Shengjian
Guo, Hui
Wang, Jack
Ahmed, Makhdum
Zhang, Victoria
Lam, Laura T.
Nomie, Krystle
Zhang, Liang
Di Francesco, Maria E.
Marszalek, Joe
Wang, Michael
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.290.290
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
290
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
    Zhao, Xiaohong
    Wang, Michelle Y.
    Jiang, Huijuan
    Lwin, Tint
    Park, Paul M.
    Gao, Jing
    Meads, Mark B.
    Ren, Yuan
    Li, Tao
    Sun, Jiao
    Fahmi, Naima Ahmed
    Singh, Satishkumar
    Sehgal, Lalit
    Wang, Xuefeng
    Silva, Ariosto S.
    Sotomayor, Eduardo M.
    Shain, Kenneth H.
    Cleveland, John L.
    Wang, Michael
    Zhang, Wei
    Qi, Jun
    Shah, Bijal D.
    Tao, Jianguo
    CELL REPORTS, 2021, 34 (11):
  • [22] The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Liu, Yang
    Zhao, Shuangtao
    Jiang, Changying
    Yao, Yixin
    Murfin, Kelley Paige
    Grundman, Hadley
    Zhang, Liang
    Nomie, Krystle
    Wang, Linghua
    Wang, Michael
    BLOOD, 2019, 134
  • [23] HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
    Jacobson, Caron
    Kopp, Nadja
    Layer, Jacob V.
    Redd, Robert A.
    Tschuri, Sebastian
    Haebe, Sarah
    van Bodegom, Diederik
    Bird, Liat
    Christie, Amanda L.
    Christodoulou, Alexandra
    Saur, Amy
    Tivey, Trevor
    Zapf, Stefanie
    Bararia, Deepak
    Zimber-Strobl, Ursula
    Rodig, Scott J.
    Weigert, Oliver
    Weinstock, David M.
    BLOOD, 2016, 128 (21) : 2517 - 2526
  • [24] Developing Novel Therapeutic Strategies to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Lan Pham
    Zhang, Liang
    Tao, Wenjing
    Zhao, Donglu
    Zhang, Hui
    Xie, Jingmeng
    Wang, Jack
    Nomie, Krystle
    Wang, Michael
    BLOOD, 2015, 126 (23)
  • [25] Mantle cell lymphoma of the iris treated by ibrutinib
    De Gauzy, T. Sales
    Oberic, L.
    Fournie, P.
    Soler, V.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (10): : E501 - E502
  • [26] Genetically Defined Metabolic Targets Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
    Zhang, Liang
    Guo, Hui
    Zhang, Hui
    Yao, Yixin
    Liu, Yang
    Zhang, Shaojun
    Rui, Lixin
    Wang, Linghua
    Nomie, Krystle
    Wang, Michael L.
    BLOOD, 2019, 134
  • [27] Oncogenic MALT1 Promotes Cell Survival and Mediates Ibrutinib Resistance and Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma
    Jiang, Vivian Changying
    Lian, Junwei
    Huang, Shengjian
    Zhang, Shaojun
    Liu, Yang
    Wang, Linghua
    Wang, Michael
    BLOOD, 2020, 136
  • [28] Mechanism of action of Ibrutinib in mantle cell lymphoma
    Sun, Zhijian
    Zhou, Dongping
    Wei, Min
    Luo, Lusong
    CANCER RESEARCH, 2014, 74 (19)
  • [29] Inhibition of MAPK-ERK Signaling Pathway Overcomes Microrna-Mediated Ibrutinib Resistance in Mantle Cell Lymphoma
    Kersy, Olga
    Salmon-Divon, Mali
    da Silva, Maria Gomes
    Moita, Ana Filipa
    Cabecadas, Jose
    Klener, Pavel, Jr.
    Trneny, Marek
    Basood, May
    Shpilberg, Ofer
    Hershkovitz-Rokah, Oshrat
    BLOOD, 2022, 140 : 3109 - 3110
  • [30] Targeting PI3K and PLK1 to Overcome Ibrutinib-Venetoclax Resistance in Mantle Cell Lymphoma
    Jiang, Changying
    Zhang, Rongjia
    Zhang, Shaojun
    Lee, William
    Huang, Shengjian
    Liu, Yang
    Leeming, Angela
    McIntosh, Joseph Mitchell
    Jain, Preetesh
    Nomie, Krystle
    Wang, Linghua
    Wang, Michael L.
    BLOOD, 2019, 134
12345